Searched for
INDIA PHARMACEUTICAL COMPANIES
Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...- 5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...
- The $50-billion question: Who gets what as India and Canada aim to strike a trade deal?India and Canada are currently negotiating a free trade agreement designed to enhance bilateral trade significantly. Nearly 300 Canadian bu...
- India sixth among major investment partners in Trump's $11.3 trillion US investment push: White HouseUnder Donald Trump's administration, the United States secured USD 11.3 trillion in investments from various countries. Among these, India ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- Can Bonfiglioli Transmissions IPO deliver long-term growth for high-risk investors?Bonfiglioli Transmissions aims to raise Rs2,534 crore through an upcoming offer for sale. The promoter group's stake will reduce from 100% ...
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
- Biocon settles US patent dispute with Roche's Genentech, eyes 2027 Perjeta biosimilar launchBiocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...
- Modi govt’s 13 strategic disinvestments in 10 yearsThe Modi government is set to sell a 60.72% stake in IDBI Bank for ₹52,878 crore. This sale will surpass previous disinvestment efforts, ma...
- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
- India, America expanding cooperation across sectors: US ambassador Sergio GorKolkata and the United States are strengthening ties across sectors such as defence, IT, and healthcare. Recent military exercises involvin...
- Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stocks to watchIndia's CRDMO sector is on the brink of expansion, backed by solid partnerships with major pharmaceutical players and comprehensive capabil...
- NuSynth Technologies raises Rs 36.5 crore in round led by Avaana Capital, Shastra VCThe company is developing a platform to find simpler, cheaper and more efficient ways to make chemicals, said cofounders Poorvank Purohit a...
- 'Stay tuned for...': US envoy Sergio Gor on India-US ties after Modi-Trump talksUS Ambassador Sergio Gor emphasized the strengthening collaboration between India and America in defense and healthcare sectors. During an ...
- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
- Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-ShawBiocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push f...
- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
Load More
